Surgical treatment consisting ofduodenojejunal bypass with or without ileal segment interposition has been shown topermit clinical control of patients with type 2 diabetes without the need for insulin ororal hypoglycemic agents7,3. This evidence concerns the gene INS and type 2 diabetes mellitus.